BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 35817274)

  • 1. Association of Intra-individual Differences in Estimated GFR by Creatinine Versus Cystatin C With Incident Heart Failure.
    Chen DC; Shlipak MG; Scherzer R; Bansal N; Potok OA; Rifkin DE; Ix JH; Muiru AN; Hsu CY; Estrella MM
    Am J Kidney Dis; 2022 Dec; 80(6):762-772.e1. PubMed ID: 35817274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Intraindividual Difference in Estimated Glomerular Filtration Rate by Creatinine vs Cystatin C and End-stage Kidney Disease and Mortality.
    Chen DC; Shlipak MG; Scherzer R; Bauer SR; Potok OA; Rifkin DE; Ix JH; Muiru AN; Hsu CY; Estrella MM
    JAMA Netw Open; 2022 Feb; 5(2):e2148940. PubMed ID: 35175342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraindividual difference in estimated GFR by creatinine and cystatin C, cognitive trajectories and motoric cognitive risk syndrome.
    Wang J; Liu Y; Jin R; Zhao X; Wu Z; Han Z; Xu Z; Guo X; Tao L
    Nephrol Dial Transplant; 2024 Apr; 39(5):860-872. PubMed ID: 37930847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discordance Between Creatinine-Based and Cystatin C-Based Estimated GFR: Interpretation According to Performance Compared to Measured GFR.
    Wang Y; Adingwupu OM; Shlipak MG; Doria A; Estrella MM; Froissart M; Gudnason V; Grubb A; Kalil R; Mauer M; Rossing P; Seegmiller J; Coresh J; Levey AS; Inker LA
    Kidney Med; 2023 Oct; 5(10):100710. PubMed ID: 37753251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystatin C- and Creatinine-based Estimated GFR Differences: Prevalence and Predictors in the UK Biobank.
    Chen DC; Lu K; Scherzer R; Lees JS; Rutherford E; Mark PB; Potok OA; Rifkin DE; Ix JH; Shlipak MG; Estrella MM
    Kidney Med; 2024 Apr; 6(4):100796. PubMed ID: 38567244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Difference Between Cystatin C- and Creatinine-Based Estimated GFR and Associations With Frailty and Adverse Outcomes: A Cohort Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT).
    Potok OA; Ix JH; Shlipak MG; Katz R; Hawfield AT; Rocco MV; Ambrosius WT; Cho ME; Pajewski NM; Rastogi A; Rifkin DE
    Am J Kidney Dis; 2020 Dec; 76(6):765-774. PubMed ID: 32682697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discordances Between Creatinine- and Cystatin C-Based Estimated GFR and Adverse Clinical Outcomes in Routine Clinical Practice.
    Carrero JJ; Fu EL; Sang Y; Ballew S; Evans M; Elinder CG; Barany P; Inker LA; Levey AS; Coresh J; Grams ME
    Am J Kidney Dis; 2023 Nov; 82(5):534-542. PubMed ID: 37354936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of Association of Cystatin C With Kidney and Cardiovascular Outcomes by Obesity.
    Chen DC; Scherzer R; Ix JH; Kramer HJ; Crews DC; Nadkarni G; Gutierrez O; Bullen AL; Ilori T; Garimella PS; Shlipak MG; Estrella MM
    Am J Kidney Dis; 2024 Apr; 83(4):489-496.e1. PubMed ID: 37866793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Creatinine- and cystatin C-based estimated glomerular filtration rate slopes for the prediction of kidney outcome: a comparative retrospective study.
    Kim S; Hwang S; Jang HR; Sohn I; Ahn HS; Park HD; Huh W; Jin DC; Kim YG; Kim DJ; Oh HY; Lee JE
    BMC Nephrol; 2019 Jun; 20(1):214. PubMed ID: 31185945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of the 2021 Race-Free CKD-EPI Creatinine- and Cystatin C-Based Estimated GFR Equations Among Kidney Transplant Recipients.
    Hundemer GL; White CA; Norman PA; Knoll GA; Tangri N; Sood MM; Hiremath S; Burns KD; McCudden C; Akbari A
    Am J Kidney Dis; 2022 Oct; 80(4):462-472.e1. PubMed ID: 35588905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential Associations of Cystatin C Versus Creatinine-Based Kidney Function With Risks of Cardiovascular Event and Mortality Among South Asian Individuals in the UK Biobank.
    Chen DC; Lees JS; Lu K; Scherzer R; Rutherford E; Mark PB; Kanaya AM; Shlipak MG; Estrella MM
    J Am Heart Assoc; 2023 Feb; 12(3):e027079. PubMed ID: 36695320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystatin C- and creatinine-based estimated glomerular filtration rate, vascular disease, and mortality in persons with diabetes in the U.S.
    Tsai CW; Grams ME; Inker LA; Coresh J; Selvin E
    Diabetes Care; 2014 Apr; 37(4):1002-8. PubMed ID: 24271191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimated GFR Accuracy When Cystatin C- and Creatinine-Based Estimates Are Discrepant in Older Adults.
    Potok OA; Rifkin DE; Ix JH; Shlipak MG; Satish A; Schneider A; Mielke N; Schaeffner E; Ebert N
    Kidney Med; 2023 May; 5(5):100628. PubMed ID: 37168389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Association of Intraindividual Difference Between Cystatin- and Creatinine-Based Estimated GFR and Contrast-Associated Acute Kidney Injury.
    Zhang LW; Luo MQ; Zeng JL; You ZB; Chen LC; Chen JH; Lin KY; Guo YS
    Clin Interv Aging; 2024; 19():411-420. PubMed ID: 38476830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Difference Between Estimated GFR Based on Cystatin C Versus Creatinine and Incident Atrial Fibrillation: A Cohort Study of the UK Biobank.
    Heo GY; Koh HB; Jung CY; Park JT; Han SH; Yoo TH; Kang SW; Kim HW
    Am J Kidney Dis; 2024 Jun; 83(6):729-738.e1. PubMed ID: 38171411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cystatin C and Muscle Mass in Patients With Heart Failure.
    Ivey-Miranda JB; Inker LA; Griffin M; Rao V; Maulion C; Turner JM; Wilson FP; Tang WHW; Levey AS; Testani JM
    J Card Fail; 2021 Jan; 27(1):48-56. PubMed ID: 32750487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Estimated GFR Calculated Using Race-Free Equations With Kidney Failure and Mortality by Black vs Non-Black Race.
    Gutiérrez OM; Sang Y; Grams ME; Ballew SH; Surapaneni A; Matsushita K; Go AS; Shlipak MG; Inker LA; Eneanya ND; Crews DC; Powe NR; Levey AS; Coresh J;
    JAMA; 2022 Jun; 327(23):2306-2316. PubMed ID: 35667006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Cystatin C Level for Risk Stratification in Adults With Chronic Kidney Disease.
    Lees JS; Rutherford E; Stevens KI; Chen DC; Scherzer R; Estrella MM; Sullivan MK; Ebert N; Mark PB; Shlipak MG
    JAMA Netw Open; 2022 Oct; 5(10):e2238300. PubMed ID: 36282503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystatin C- and Creatinine-Based Glomerular Filtration Rate Estimation Differences and Muscle Quantity and Functional Status in Older Adults: The Health, Aging, and Body Composition Study.
    Potok OA; Ix JH; Shlipak MG; Bansal N; Katz R; Kritchevsky SB; Rifkin DE
    Kidney Med; 2022 Mar; 4(3):100416. PubMed ID: 35386603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Creatinine- versus cystatin C-based renal function assessment in the Northern Manhattan Study.
    Husain SA; Willey JZ; Park Moon Y; Elkind MSV; Sacco RL; Wolf M; Cheung K; Wright CB; Mohan S
    PLoS One; 2018; 13(11):e0206839. PubMed ID: 30427947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.